| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 111,496 | 125,229 | 115,466 | 139,011 | | Cost of Revenue | 75,835 | 82,834 | 76,914 | 97,613 | | | Gross Profit | 35,661 | 42,395 | 38,552 | 41,398 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,862 | 34,588 | 35,737 | 37,531 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,327 | 2,269 | 2,377 | 3,503 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,528) | 5,538 | 438 | 364 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,117) | 5,538 | 438 | 364 | | Interest Expense | (1,057) | 520 | 537 | 648 | | Income Before Tax | (2,060) | 5,018 | (99) | (284) | | Income Tax Expense | (626) | 1,981 | (45) | 264 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,434) | 3,037 | (54) | (548) | | | Non-recurring Events | | Discontinued Operations | (3) | (6) | 4 | (167) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,437) | 3,031 | (50) | (715) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,437) | $3,031 | ($50) | ($715) |
|
0.03% Nasdaq 0.00%
Income Statement
